Literature DB >> 4066428

Dopaminergic drugs improve human visual contrast sensitivity.

L Domenici, C Trimarchi, M Piccolino, A Fiorentini, L Maffei.   

Abstract

Effects of dopaminergic drugs (L-dopa plus benserazide, or nomifensine) on human visual function have been tested in healthy volunteers by measuring the psychophysical contrast sensitivity for sinusoidal gratings of various spatial frequencies. After drug administration the contrast sensitivity improved in all subjects over a limited range of medium to high spatial frequencies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066428

Source DB:  PubMed          Journal:  Hum Neurobiol        ISSN: 0721-9075


  13 in total

1.  Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease.

Authors:  J Nguyen-Legros
Journal:  Surg Radiol Anat       Date:  1988       Impact factor: 1.246

2.  Light- and dopamine-regulated receptive field plasticity in primate horizontal cells.

Authors:  Ai-Jun Zhang; Roy Jacoby; Samuel M Wu
Journal:  J Comp Neurol       Date:  2011-08-01       Impact factor: 3.215

Review 3.  Effects of dietary polyunsaturated fatty acids on neuronal function.

Authors:  J D Fernstrom
Journal:  Lipids       Date:  1999-02       Impact factor: 1.880

4.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

5.  Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study.

Authors:  O Blin; D Mestre; G Masson; G Serratrice
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

6.  Little effect of 0.01% atropine eye drops as used in myopia prevention on the pattern electroretinogram.

Authors:  Lisa-Marie Anders; Sven P Heinrich; Wolf A Lagrèze; Lutz Joachimsen
Journal:  Doc Ophthalmol       Date:  2019-01-24       Impact factor: 2.379

7.  Executive function impairment in early-treated PKU subjects with normal mental development.

Authors:  V Leuzzi; M Pansini; E Sechi; F Chiarotti; Cl Carducci; G Levi; I Antonozzi
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

8.  Specific effects of the benzodiazepine midazolam on visual receptive fields in light and dark adapted human subjects.

Authors:  M Groner; H U Fisch; F Walder; R Groner; D Hofer; U Koelbing; I Duss; R Bianchi; B Bircher
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Treatment of Visual Disorders in Parkinson Disease.

Authors:  Joseph Savitt; Michaela Mathews
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

10.  Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease.

Authors:  F Sartucci; G Orlandi; U Bonuccelli; D Borghetti; L Murri; C Orsini; L Domenici; V Porciatti
Journal:  Neurol Sci       Date:  2006-02       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.